ChromaDex Announces Strategic Partnership for Aging Research with Jiangxi Government in China

Longevity Investing

ChromaDex (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age with its flagship ingredient NIAGEN and consumer product TRU NIAGEN, today announced a strategic partnership for healthy aging research with the Jiangxi Provincial Government, People’s Republic of China. As quoted in the press release: Wu Zhongqiong, Vice Governor of the People’s Government of …

ChromaDex (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age with its flagship ingredient NIAGEN and consumer product TRU NIAGEN, today announced a strategic partnership for healthy aging research with the Jiangxi Provincial Government, People’s Republic of China.

As quoted in the press release:

Wu Zhongqiong, Vice Governor of the People’s Government of Jiangxi Province, commenced the ceremony at the Jiangxi Qianhu State Guesthouse on Thurs., Sept. 13. Additional presentations followed from Madame Wang of Qifeng Food Technology, Dr. Katherine Lo of the Li Ka Shing Foundation, Robert Fried of ChromaDex, and Drs. Charles Brenner and Roger Kornberg of the ChromaDex Scientific Advisory Board.

“We are grateful to have met with the leaders of the great province of Jiangxi and look forward to furthering this relationship,” says ChromaDex CEO Rob Fried. “This is an important first step in our long-term commitment to China.”

“This is a momentous occasion here in Jiangxi,” says Kornberg, who won the Nobel Prize in Chemistry in 2006. “I look forward to the research and progress in the study of aging that will come from this new initiative.”

“I’m thrilled to present the foundational science of nicotinamide riboside (NR) and the safe, evidence-based commercialization of our ingredient to Nanchang and Jiangxi Province,” says Brenner. “The global interest in our technology is exciting, and I look forward to advancing our research and development even further.” Brenner discovered NR and is the Chief Scientific Advisor at ChromaDex.

Click here to read the full press release.

The Conversation (0)
×